{
    "organizations": [],
    "uuid": "e44e42310043998ac417977ae838f9a914963518",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-changzhou-qianhong-biopharma-sees/brief-changzhou-qianhong-biopharma-sees-fy-2018-h1-net-profit-up-10-pct-to-30-pct-idUSL3N1RX49H",
    "ord_in_thread": 0,
    "title": "BRIEF-Changzhou Qianhong Biopharma sees FY 2018 H1 net profit up 10 pct to 30 pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 20(Reuters) - Changzhou Qianhong Biopharma Co Ltd\n* Sees FY 2018 H1 net profit to increase by 10 percent to 30 percent, or to be 158.4 million yuan to 187.2 million yuan\n* Says FY 2017 H1 net profit was 144 million yuan\nSource text in Chinese: goo.gl/GeBfjv\nFurther company coverage: (Beijing Headline News)\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-04-20T18:18:00.000+03:00",
    "crawled": "2018-04-21T18:05:51.010+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "changzhou",
        "qianhong",
        "biopharma",
        "co",
        "ltd",
        "see",
        "fy",
        "h1",
        "net",
        "profit",
        "increase",
        "percent",
        "percent",
        "million",
        "yuan",
        "million",
        "yuan",
        "say",
        "fy",
        "h1",
        "net",
        "profit",
        "million",
        "yuan",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}